(Q45232701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Synthesis and potential anti-inflammatory activity of some tetrahydrophthalazinones (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Benoit Pinel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jean-Francois Cupif

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Alexandra Depince

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Corinne A E Martin-Chouly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Chantal Belleguic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Michele David

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

Journal of Enzyme Inhibition and Medicinal Chemistry

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

475-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology of airway inflammation in asthma and COPD.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

Phosphodiesterase isozymes: molecular targets for novel antiasthma agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

Pharmacology of a new cyclic nucleotide phosphodiesterase type 4 inhibitor, V11294.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleuk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14756360412331280536

10.1080/14756360412331280536

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15662951%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference